TickerFacts.

Niagen Bioscience, Inc. (NAGE): Capital Expenditures

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Capital Expenditures is for the year ended 2019-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$743.0K
Year ended 2019-12-31
-21.0%
3-year compound annual growth
+43.3%
5-year compound annual growth
$1.50M2011-01-01: $169.1K2011-12-31: $150.7K2012-12-29: $24.6K2013-12-28: $137.3K2015-01-03: $123.1K2016-01-02: $525.2K2016-12-31: $1.50M2017-12-30: $1.17M2018-12-31: $1.32M2019-12-31: $743.0K$743.0K
2011-01-01 Capital Expenditures (USD) 2019-12-31
Period endedCapital ExpendituresChange YoYSource filing
2019-12-31$743.0K-43.8%2020-03-10, From 2019-01-01
2018-12-31$1.32M+13.2%2020-03-10, From 2017-12-31
2017-12-30$1.17M-22.5%2019-03-07, From 2017-01-01
2016-12-31$1.50M+186.5%2018-03-15, From 2016-01-03
2016-01-02, Fiscal 2015$525.2K+326.7%2018-03-15, From 2015-01-04
2015-01-03, Fiscal 2014$123.1K-10.4%2017-03-16, From 2013-12-29
2013-12-28$137.3K+459.4%2016-03-17, From 2012-12-30
2012-12-29$24.6K-83.7%2014-03-27, From 2012-01-01
2011-12-31$150.7K-10.9%2013-03-29, From 2011-01-02
2011-01-01, Fiscal 2010$169.1Kn/a2012-03-15, From 2010-01-03